Sangamo BioSciences | SGMO - درآمد حاصل از بهره

قیمت سهام
0.25
تغییر روزانه
-0.01 -4.09%
ماهیانه
-38.64%
سالیانه
-65.04%
Q2 پیش بینی
0.24




درآمد حاصل از بهره تغییر دادن تاریخ
Alnylam Pharmaceuticals USD 28.68M 1.19M 2025-09
Bayer EUR 130M 38M 2025-09
BioCryst Pharmaceuticals USD -0.13 3.59M 2024-12
Biogen USD 31.6M 700K 2025-09
BioMarin Pharmaceutical USD 17.85M 973K 2025-09
Compugen USD 954K 116K 2025-09
CSL USD 18M 1000K 2024-12
Gilead Sciences USD 88M 15M 2025-09
GlaxoSmithKline GBP 26M 24M 2025-09
Ionis Pharmaceuticals USD -0.66 0.29 2024-12
J&J USD 2.12 0.17 2025-09
Karyopharm Therapeutics USD -0.15 0.11 2024-12
Merck USD 96M 27M 2025-09
Pfizer USD 0.62 156M 2025-09
Sanofi EUR 114M 38M 2025-09
Sarepta Therapeutics USD 8.38M 1.24M 2025-09
Tectonic Therapeutic USD 1.74M 217K 2024-12
Ultragenyx Pharmaceutical USD 5.86M 69K 2025-09
Vertex Pharmaceuticals USD 125.7M 3.3M 2025-09